On July 24, Hca Healthcare Inc rose 3.76% in regular trading, trading at $389.86/share, with turnover of $53.31 million. The stock gained after the company reported second-quarter results that significantly exceeded analyst expectations on both the top and bottom lines.

For Q2, HCA reported revenue of $20.23 billion, up from $18.61 billion a year earlier, beating the consensus estimate of approximately $19.4-19.76 billion. Adjusted EPS came in at $7.59, representing a 10.96% increase over $6.84 a year ago and surpassing the Street estimate of $7.02-7.56. Same-facility admissions grew 2.5% year-over-year, while emergency room visits increased 3.6%, indicating robust demand trends. Adjusted EBITDA reached $4.027 billion, up 4.6%. However, the company lowered its full-year profit guidance, citing approximately $400 million in pre-tax earnings impact from a shift in patient payment mix toward uninsured patients. Full-year adjusted EBITDA expectations were reduced to $15.4-16.1 billion.

Within the Health Care Facilities sector, peers rallied broadly: Tenet Healthcare up 22.67%, Surgery Partners up 6.18%, Universal Health up 5.59%, Encompass Health Corporation up 3.15%, US Physical Therapy up 2.21%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)